Showing 681 - 700 results of 108,045 for search '(( 16 we decrease ) OR ( 5 ((step decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.66s Refine Results
  1. 681

    Inhibition of IL-17A at tumor sites decreases the intratumoral microvessel density. by Keiji Hayata (277090)

    Published 2013
    “…<p>(A) The endothelial maker CD31-stained sections of tumor tissue are shown in Ad-SNC and Ad-si-IL-17 treatment models, Ad-si-IL-17 treatment decreased the intratumoral microvessel density compared with Ad-SNC. …”
  2. 682
  3. 683

    Ectopic Expression of a Maize Hybrid Down-Regulated Gene <i>ZmARF25</i> Decreases Organ Size by Affecting Cellular Proliferation in <i>Arabidopsis</i> by Chuan Li (158692)

    Published 2014
    “…Moreover, overexpression of <i>ZmARF25</i> led to reduced organ size in <i>Arabidopsis</i>, which was mainly due to the decrease in cell number, not cell size. In addition, the cell proliferation related genes <i>AtANT, AtGIF1</i> and <i>AtGRF5</i> were down-regulated in 35S::<i>ZmARF25</i> transgenic lines. …”
  4. 684

    Image_5_Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.tif by Ozair Abawi (8816267)

    Published 2022
    “…Mean REE% was higher in children with non-syndromic genetic obesity (107.4% ± 12.7) and lower in children with hypothalamic obesity (87.6% ± 14.2) compared to multifactorial obesity (100.5% ± 12.6, both p<0.01). In 9 children with pseudohypoparathyroidism type 1a, mean REE% was similar (100.4 ± 5.1). …”
  5. 685
  6. 686
  7. 687
  8. 688
  9. 689
  10. 690

    Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM. by Masami Kishi (6167105)

    Published 2018
    “…The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
  11. 691
  12. 692
  13. 693
  14. 694
  15. 695

    Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. by Brian Onken (86790)

    Published 2020
    “…Trials with 5 and 13 day old animals also showed impaired older age locomotion in 4% glucose (Supplemental <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008982#pgen.1008982.s002" target="_blank">S1A and S1B Fig</a>). …”
  16. 696
  17. 697

    Attenuation of spheroid size decrease or MUC5AC increase by hit compounds. by Pranjali Beri (14945400)

    Published 2023
    “…<p>Final hit compounds (with hit concentration and corresponding target) that <b>A)</b> increased bronchosphere size compared to DMSO + 3% CSE control bronchospheres or <b>B)</b> decreased secreted MUC5AC. …”
  18. 698

    Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

    Published 2014
    “…<p>(A) Turnover rates, as measured by 5-HIAA:5-HT ratios, normalized to the values of vehicle-treated animals, for the following drugs: fluoxetine (FLX; chronic treatment with 10 mg/kg); chlordiazepoxide (CDZ; 0.02 mg/kg); clonazepam (CLZ; 0.05 mg/kg); diazepam (DZP; 1.25 mg/kg); buspirone (BUS; 50 mg/kg); ethanol (EtOH, 2.5%); dizocilpine (MK; 0.005 mg/kg); verapamil (VER; 5 mg/kg); WAY 100,635 (WAY; 0.03 mg/kg); and SB 224,289 (SB; 2.5 mg/kg). …”
  19. 699
  20. 700

    Nimodipine does not decrease markers of neuritic dystrophy in 5XFAD transgenic mice. by Katherine R. Sadleir (12035242)

    Published 2022
    “…<p><b>(</b>A and F) Representative immunoblots of hippocampal (A) and cortical (F) lysates of non-transgenic and 5XFAD mice treated with vehicle or nimodipine. …”